43 related articles for article (PubMed ID: 35670324)
21. Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus.
Daneshpazhooh M; Tavakolpour S; Salehi Farid A; Ebadi M; Nili A; Rashidian M; Mahmoudi H
Int J Dermatol; 2022 Jan; 61(1):e14-e17. PubMed ID: 34156705
[No Abstract] [Full Text] [Related]
22. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes.
Rawat BPS; Jagannatha A; Liu F; Yu H
AMIA Annu Symp Proc; 2020; 2020():1041-1049. PubMed ID: 33936480
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of neutrophil inflammatory mediator expression by azithromycin.
Gibson MP; Walters JD
Clin Oral Investig; 2020 Dec; 24(12):4493-4500. PubMed ID: 32436162
[TBL] [Abstract][Full Text] [Related]
24. Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil.
Costa DAM; Seque CA; Enokihara MMSS; Porro AM
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):e52-e55. PubMed ID: 29992639
[No Abstract] [Full Text] [Related]
25. Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1.
Wang Y; Zhang Y; Peng G; Han X
Int Immunopharmacol; 2018 Jul; 60():9-17. PubMed ID: 29702284
[TBL] [Abstract][Full Text] [Related]
26. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials.
Yu JJ; Zhang CS; Coyle ME; Du Y; Zhang AL; Guo X; Xue CC; Lu C
Curr Med Res Opin; 2017 Feb; 33(2):279-287. PubMed ID: 27786567
[TBL] [Abstract][Full Text] [Related]
27. Acute generalized exanthematous pustulosis induced by etanercept: another dermatologic adverse effect.
Kavala M; Zindancı I; Türkoglu Z; Can B; Kocatürk E; Senol S; Topaloglu F
Case Rep Dermatol Med; 2013; 2013():601412. PubMed ID: 23573431
[TBL] [Abstract][Full Text] [Related]
28. Acute Generalized Exanthematous Pustulosis due to Tocilizumab in a Rheumatoid Arthritis Patient.
Izquierdo JH; Bonilla-Abadía F; Ochoa CD; Agualimpia A; Tobón GJ; Cañas CA
Case Rep Rheumatol; 2012; 2012():517424. PubMed ID: 23304614
[TBL] [Abstract][Full Text] [Related]
29. Clinical practice. Exanthematous drug eruptions.
Stern RS
N Engl J Med; 2012 Jun; 366(26):2492-501. PubMed ID: 22738099
[No Abstract] [Full Text] [Related]
30. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).
Sidoroff A; Dunant A; Viboud C; Halevy S; Bavinck JN; Naldi L; Mockenhaupt M; Fagot JP; Roujeau JC
Br J Dermatol; 2007 Nov; 157(5):989-96. PubMed ID: 17854366
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Castner NB; Harris JC; Motaparthi K
Dermatol Ther; 2018 Sep; 31(5):e12660. PubMed ID: 30152569
[TBL] [Abstract][Full Text] [Related]
32. Acute generalized exanthematous pustulosis (AGEP): A review and update.
Szatkowski J; Schwartz RA
J Am Acad Dermatol; 2015 Nov; 73(5):843-8. PubMed ID: 26354880
[TBL] [Abstract][Full Text] [Related]
33. Acute localized exanthematous pustulosis: Clinical features, pathophysiology, and therapy.
Safa I; Ines L; Noureddine L; Meriem J; Manel N; Belhajali H; Faten Z; Zili J
Dermatol Ther; 2021 Sep; 34(5):e15087. PubMed ID: 34351040
[TBL] [Abstract][Full Text] [Related]
34. Acute localised exanthematous pustulosis: Case report, review of the literature and proposed diagnostic criteria.
Ryder ENC; Perkins W
Australas J Dermatol; 2018 Aug; 59(3):226-227. PubMed ID: 28952145
[No Abstract] [Full Text] [Related]
35. Results of patch testing in acute generalized exanthematous pustulosis (AGEP): A literature review.
de Groot AC
Contact Dermatitis; 2022 Aug; 87(2):119-141. PubMed ID: 35187690
[TBL] [Abstract][Full Text] [Related]
36. Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis.
Wu L; Ali K; Qiu Y; Li M; Da J
Acta Derm Venereol; 2022 Jun; 102():adv00743. PubMed ID: 35670324
[TBL] [Abstract][Full Text] [Related]
37. Acute generalized exanthematous pustulosis due to terbinafine.
Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
